NWPF

News ArchivesRead News

Michael J. Fox and Parkinson’s Disease

Thursday June 30, 2005

Exact causes still a mystery
Mary Kugler

About - Between one and one-and-a-half million Americans are affected by Parkinson’s disease, a disorder of the central nervous system. "Parkinson’s" is the overall term for at least six different categoriesof the disorder, which usually affects people age 50 or older.

About 10-20% of people with Parkinson’s are diagnosed before age 50; only half of these people are diagnosed before age 40. This is called juvenile Parkinson’s. Michael J. Fox, diagnosed at age 30 years old in 1991, is in this category.

Possible causes People with Parkinson’s disease have a shortage of a chemical that affects movement (called dopamine) in their brains.

Treatment of Parkinson’s disease has traditionally been with medication that can be made into dopamine in the brain (Sinemet), or by drugs that seem to affect the use of dopamine in the brain (Symmetrel, Eldepryl). Newer drugs, called dopamine agonists (Parlodel, Permax, Mirapex, Requip), activate dopamine-sensitive brain cells.

Surgical treatments One technique being investigated is high-frequency stimulation of a part of the brain called the subthalamic nucleus. This is known as deep brain stimulation. Brain tissue transplants using genetically-altered cells, fetal tissue, or pig tissue introduce cells to produce dopamine. New techniques for thalamotomy and pallidotomy, which destroy the "trouble-causing" cells in the brain using an electrode, are being developed.

Michael J. Fox has established The Michael J. Fox Foundation for Parkinson’s Research. He has spoken out in favor of stem cell research and has worked tirelessly to raise money for research. The Foundation Web site states, "Fox wholeheartedly believes that if there is a concentrated effort from the Parkinson’s community, elected representatives in Washington, DC, and (most importantly) the general public, researchers can pinpoint the cause of Parkinson’s and uncover a cure by 2010."

Recent News

Aug 22 - Parkinson's Disease Could Be Diagnosed Through Eye Check, Mice Help Researchers In Further Study
Aug 22 - Machine learning to unlock Parkinson's disease mystery
Aug 21 - Cognitive control plays major role in Parkinson’s Gait
Aug 15 - 'I've Never Felt Constrained': After Parkinson's Diagnosis, Chestnut Hill Man Turns To Drumming
Aug 11 - Virtual reality and treadmill training could help prevent falls in older adults
Aug 9 - New laboratory model replicates early phase of Parkinson's before onset of motor symptoms
Aug 8 - Marshall University Scientists Develop A New Approach For Parkinson’s Disease Therapy
Aug 5 - Cambuslang woman diagnosed with Parkinson's at 42 is set to trek through Alps
Aug 4 - Active Music Therapy May Be Beneficial in Parkinson's
Aug 1 - Mini-Brains? Scientists Grow Rice Grain-Sized Brains to Aid Parkinson’s Research
Jul 30 - Lab method sheds light on how genetic mutations cause inherited Parkinson's disease
Jul 27 - Indicators of Parkinson's disease risk found in unexpected places
Jul 24 - Parkinson's: Mutant gene interaction may pave the way for new treatments
Jul 22 - Boxing training used to fight against Parkinson's disease
Jul 17 - Stem cell treatment breakthrough could cure Parkinson’s patients
Jul 14 - Cancer drug shows early promise for Parkinson's disease
Jul 13 - Opinion: Dividing the Caregiving Responsibilities Between Siblings
Jul 12 - Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases
Jul 11 - Parkinson’s Head Trauma Link Looks Even Stronger
Jul 7 - Penn students’ start-up XEED puts wearables to work against Parkinson’s disease